Trimedyne, Inc. reported financial results for the first quarter ended December 31, 2013. Revenues for the quarter ended December 31, 2013, were $1,399,000, a 5.2% decrease from revenues of $1,475,000 for the prior year's quarter. The company had a net loss of $259,000 or $0.014 per share for the current quarter, compared to a loss of $144,000 or $0.008 per share for the same quarter of the prior year, based on a weighted average of 18,395,960 shares outstanding.
1st Jan change | Capi. | |
---|---|---|
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+0.99% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |